MX2018004029A - Deteccion de analitos con multiples sustratos. - Google Patents

Deteccion de analitos con multiples sustratos.

Info

Publication number
MX2018004029A
MX2018004029A MX2018004029A MX2018004029A MX2018004029A MX 2018004029 A MX2018004029 A MX 2018004029A MX 2018004029 A MX2018004029 A MX 2018004029A MX 2018004029 A MX2018004029 A MX 2018004029A MX 2018004029 A MX2018004029 A MX 2018004029A
Authority
MX
Mexico
Prior art keywords
analyte
binding
agent
analyte detection
multiple substrates
Prior art date
Application number
MX2018004029A
Other languages
English (en)
Inventor
James Sheehan Antony
Francis CROUCH Michael
Original Assignee
Tgr Biosciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tgr Biosciences Pty Ltd filed Critical Tgr Biosciences Pty Ltd
Publication of MX2018004029A publication Critical patent/MX2018004029A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Abstract

La presente descripción provee métodos y/o kits para detectar un analito en una muestra. Algunas modalidades proveen un sistema de detección de analitos, kit y método para usar el mismo, que comprende: un primer agente que comprende al menos una etiqueta y capaz de unirse al analito; un segundo agente covalentemente unido a una pluralidad de etiquetas de póptido y capaz de unirse al analito; una primera perla que comprende un aglutinante capaz de unirse con el primer agente etiquetado; y una segunda perla que comprende un agente anti-póptido capaz de unirse con al menos una de la pluralidad de etiquetas de póptido covalentemente unidas.
MX2018004029A 2015-10-02 2016-09-30 Deteccion de analitos con multiples sustratos. MX2018004029A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562236676P 2015-10-02 2015-10-02
US201562237522P 2015-10-05 2015-10-05
PCT/IB2016/001981 WO2017068431A1 (en) 2015-10-02 2016-09-30 Analyte detection with multiple substrates

Publications (1)

Publication Number Publication Date
MX2018004029A true MX2018004029A (es) 2018-07-06

Family

ID=58446765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004029A MX2018004029A (es) 2015-10-02 2016-09-30 Deteccion de analitos con multiples sustratos.

Country Status (9)

Country Link
US (3) US20170097339A1 (es)
EP (1) EP3356822B1 (es)
JP (1) JP2018533017A (es)
CN (1) CN108603877A (es)
AU (1) AU2016341539A1 (es)
CA (1) CA3000584A1 (es)
HK (1) HK1254374A1 (es)
MX (1) MX2018004029A (es)
WO (1) WO2017068431A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057347A1 (en) 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
WO2021070218A1 (ja) * 2019-10-07 2021-04-15 ナノティス株式会社 試料中の被検出物質を検出する方法
TWI832129B (zh) * 2020-12-28 2024-02-11 財團法人工業技術研究院 多重分析物的檢測方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135597T3 (es) 1993-09-03 1999-11-01 Dade Behring Marburg Gmbh Inmunoensayos fluorescentes de canalizacion del oxigeno.
JP2005534286A (ja) * 2002-03-21 2005-11-17 サネシス ファーマシューティカルズ， インコーポレイテッド キナーゼインヒビターの同定
US20030232394A1 (en) 2002-06-12 2003-12-18 Aventis Pharma Deutschland Gmbh High throughput screening method and assay system for determining the interaction between C-reactive protein and components binding to it
DE10226011A1 (de) * 2002-06-12 2004-01-08 Aventis Pharma Deutschland Gmbh HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
US20110008345A1 (en) * 2007-11-30 2011-01-13 Claire Ashman Antigen-binding constructs
EP2398868B1 (en) 2009-02-20 2016-06-15 Perkinelmer Biosignal, Inc. Multiplex assay methods and compositions
ES2427627T3 (es) * 2009-04-06 2013-10-31 Novo Nordisk A/S Entrega dirigida de proteínas de Factor VIII a plaquetas
WO2011057347A1 (en) * 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
WO2012129610A1 (en) * 2011-03-31 2012-10-04 Tgr Biosciences Pty Ltd One-step immunoassay detection of analytes
EP3800474B1 (en) 2011-03-31 2023-11-01 Tgr Biosciences Pty Ltd Detection of multiple analytes
GB201403875D0 (en) * 2014-03-05 2014-04-16 Cantargia Ab Novel antibodies and uses thereof
WO2016029220A1 (en) * 2014-08-22 2016-02-25 Nectagen, Inc. Affinity proteins and uses thereof
CN104897652B (zh) * 2015-03-19 2017-08-25 杭州金溪生物技术有限公司 一步均相化学发光法进行小分子检测的方法及所用微粒

Also Published As

Publication number Publication date
CA3000584A1 (en) 2017-04-27
WO2017068431A1 (en) 2017-04-27
EP3356822B1 (en) 2021-10-27
EP3356822A4 (en) 2019-07-03
JP2018533017A (ja) 2018-11-08
US20180275121A1 (en) 2018-09-27
US20170097339A1 (en) 2017-04-06
EP3356822A1 (en) 2018-08-08
CN108603877A (zh) 2018-09-28
HK1254374A1 (zh) 2019-07-19
AU2016341539A1 (en) 2018-04-26
US20180136202A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
PH12020551028A1 (en) Methods, kits and apparatus for expanding a population of cells
EP3704249A4 (en) ANALYSIS KITS USING A NUCLEIC ACID CODING AND / OR LABEL
CA2944476C (en) Azetidine-substituted fluorescent compounds
EP4270006A3 (en) General detection and isolation of specific cells by binding of labeled molecules
MY170164A (en) Aptamer-based multiplexed assays
WO2014071358A3 (en) Novel ntrk1 fusion molecules and uses thereof
EP4234716A3 (en) Methods for determining spatial patterns of biological targets in a sample
EP3258270A4 (en) Cardiac troponin i ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
PH12017501967A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
WO2015042583A3 (en) Systems, devices, & methods for microbial detection & identification, and antimicrobial susceptibility testing
GB201014028D0 (en) In-situ reagent
MX2018015213A (es) Secuencia de acido nucleico para detectar la existencia del evento de soya transgenica dbn9004 en una muestra biologica, equipo que contiene la misma y metodo de deteccion para la misma.
WO2014160903A3 (en) Biological sample processing
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
ZA202002415B (en) Detection of symmetrical dimethylarginine
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
MX2018004029A (es) Deteccion de analitos con multiples sustratos.
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
PL3634907T3 (pl) Modyfikowana węglowa matryca nanostrukturalna, zawierający taką matrycę układ i obejmujący taki układ biosensor oraz sposób oznaczania analitu w próbce z zastosowaniem układu biosensora jak również zastosowanie pochodnej kwasu benzopirolowego do modyfikowania węglowej matrycy nanostrukturalnej
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2015184321A3 (en) Rare molecule detection
SG10201807867XA (en) Simultaneous detection of target protein and target nucleic acids in a single cell
MX2020012713A (es) Metodos, dispositivos y sistemas para cuantificar biomarcadores.
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EA202090515A1 (ru) Капиллярное изоэлектрическое фокусирование с детектированием непосредственно в капилляре для анализа вариантов белка в матрице образца